Empresa XOMA Corp Nasdaq
Acciones
US98419J1079
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 6 | 100,0 % | 5 | 100,0 % | -21,06 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
76,9
%
| 4 | 74,3 % | 4 | 76,9 % | -18,29 % |
Asia Pacific
23,1
%
| 2 | 25,7 % | 1 | 23,1 % | -29,03 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Owen Hughes
CEO | Chief Executive Officer | 49 | 01/01/23 |
Thomas Burns
DFI | Director of Finance/CFO | 50 | 14/08/06 |
Bradley Sitko
CIO | Chief Investment Officer | 43 | 03/01/23 |
Juliane Snowden
IRC | Investor Relations Contact | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Heather Franklin
BRD | Director/Board Member | 58 | 06/08/21 |
Chairman | 68 | 26/08/10 | |
Joseph Limber
BRD | Director/Board Member | 71 | 12/12/12 |
Matthew Perry
BRD | Director/Board Member | 51 | 16/02/17 |
Barbara Kosacz
BRD | Director/Board Member | 66 | 01/01/19 |
Owen Hughes
CEO | Chief Executive Officer | 49 | 01/01/23 |
Natasha Hernday
BRD | Director/Board Member | 52 | 30/06/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 984 000 | 0 | 0 | 99,58 % |
Acción B | 1 | 11 635 015 | 11 587 438 ( 99,59 %) | 0 | |
Acción C | 0 | 1 600 | 0 | 0 |
Información de la empresa
Sector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,97 % | 108 mil M | |
+10,21 % | 105 mil M | |
+1,57 % | 23,46 mil M | |
-12,77 % | 21,72 mil M | |
-7,05 % | 18,64 mil M | |
-37,64 % | 17,45 mil M | |
-6,50 % | 17,19 mil M | |
+6,00 % | 13,99 mil M | |
+37,20 % | 12,53 mil M |